Clinical Trial

Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

Study acronym: VITAL
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2024 (before its estimated January 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-20.
Status change: Active, Not Recruiting → Recruiting 2024-09-25
Trial Details
NCT Number NCT06611020
Lead Sponsor Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Conditions Cervical Intraepithelial Neoplasia
Enrollment 600 participants
Start Date 2020-01-01
Primary Completion 2025-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-26